GRI Bio increases ATM offering capacity by up to $1.04M, excluding prior $0.96M sales

GRI Bio, Inc.

Increased maximum aggregate sales price of shares under ATM agreement with H.C. Wainwright to $1,038,886, excluding $961,272 already sold.
ATM agreement originally dated May 20, 2024; prospectus supplement filed July 19, 2024.
Shares to be issued are common stock, par value $0.0001 per share; legal opinion from Mintz, Levin filed as exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.